MedPath

北京亦嘉新创医疗器械技术研究院有限公司

Ownership
-
Established
2017-04-27
Employees
-
Market Cap
-
Website
www.yijiaxinchuang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Ambroxol hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20258053
Approval Date
Apr 3, 2025
NMPA

Levetiracetam Oral Solution

Product Name
左乙拉西坦口服溶液
Approval Number
国药准字H20244777
Approval Date
Sep 3, 2024
NMPA

Ambroxol hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20213746
Approval Date
Sep 24, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.